Prime Highlights-
- Cipla appointed Taher Karampurwala as Senior Director and Head of Middle East Business.
- The company will strengthen its presence in the Middle East, with leadership based in Saudi Arabia.
Key Facts-
- Cipla is an Indian pharmaceutical company with a strong global presence in medicines and healthcare solutions.
- Taher Karampurwala has over 15 years of experience in pharma and has worked with Sun Pharma and Ranbaxy.
Background-
Cipla has appointed Taher Karampurwala as Senior Director and Head of Middle East Business. The move is aimed at strengthening its leadership as the company expands in international markets.
In his new role, Karampurwala will move to Saudi Arabia and manage Cipla’s operations and growth plans across the Middle East. The company said the decision reflects its focus on growing its global presence in key markets.
Before this, he worked as Cluster Head for the Middle East at Cipla. He also served as Associate Director for APAC B2B Business, where he handled several international markets and was responsible for business performance and profits. His work included handling formulation businesses and helping expand market growth.
He has over 15 years of experience in the pharmaceutical sector. He has worked in business development, international operations, and partnerships. Before joining Cipla, he worked with Sun Pharma and Ranbaxy, where he handled business growth projects, licensing agreements, mergers and global collaborations.
The Middle East is an important market for Cipla as it continues to grow its international business. The leadership change is expected to help the company improve its presence and performance in the region.
The company said the appointment will support its long-term growth plans in emerging markets.It is expected to improve the company’s presence in important international markets. The move will also help improve business execution and support expansion across important markets.
